Teste Rápido: Melasma

Dr. Reinaldo Hamamoto

Notificação

31 de maio de 2022

Referências

  1. Plensdorf S, Livieratos M, Dada N. Pigmentation Disorders: Diagnosis and Management. Am Fam Physician. 2017; 96(12):797-804.

  2. Cestari T, Arellano I, Hexsel D, Ortonne JP; Latin American Pigmentary Disorders Academy. Melasma in Latin America: options for therapy and treatment algorithm. J Eur Acad Dermatol Venereol. 2009; 23(7):760-772. Fonte

  3. Arellano MI. Guías de diagnóstico y manejo de melasma. Dermatología Cosmética, Médica y Quirúrgica. 2018; 16(1):12-23.

  4. Sociedade Brasileira de Dermatologia SBD Nosologic profile of dermatologic visits in Brazil. 2006; 81:545–554.

  5. Failmezger C. Incidence of skin disease in Cuzco, Peru. Int J Derm 1992; 31:560–561.

  6. Hexsel D, Arellano I, Rendon M. Ethnic considerations in the treatment of Hispanic and Latin-American patients with hyperpigmentation. Br J Dermatol 2006; 156(Suppl. 1):7–12

  7. Hexsel D, Lacerda DA, Cavalcante AS, Machado Filho CA, Kalil CL, Ayres EL, et al. Epidemiology of melasma in Brazilian patients: a multicenter study. Int J Dermatol. 2013; 53:440–444

  8. Achar A, Rathi SK. Melasma: a clinico-epidemiological study of 312 cases. Indian J Dermatol. 2011; 56:380–382.

  9. Goh CL, Dlova CN. A retrospective study on the clinical presentation and treatment outcome of melasma in a tertiary dermatological referral centre in Singapore. Singapore Med J. 1999; 40:455–458.

  10. Ai-Young L, Recent progress in melasma pathogenesis, Pigment Cell Melanoma Res 2015; 28(6):648-60.

  11. Grimes PE, Yamada N, Bhawan J. Light microscopic, immunohistochemical, and ultrastructural alterations in patients with melasma. Am J Dermatopathol. 2005; 27:96-101.

  12. Sanchez NP, Pathak MA, Sato S, et al. Melasma: a clinical, light microscopic, ultrastructural, and immunofluorescence study. J Am Acad Dermatol. 1981; 4:698-710.

  13. Kwon S, Hwang Y, Lee S, Park K. Heterogeneous Pathology of Melasma and Its Clinical Implications. Int J Mol Sci. 2016; 17:824.

  14. Kang HY, Hwang JS, Lee DJ, et al. The dermal stem cell factor and c-kit are overexpressed in melasma. Br J Dermatol. 2006; 154:1094-1099.

  15. Gledhill K, Rhodes LE, Brownrigg M, et al.  Prostaglandin-E2 is produced by adult human epidermal melanocytes in response to UVB in a melanogenesis-dependent manner. Pigment Cell Melanoma Res. 2010; 23:394-403.

  16. Videira IFS, Moura DFL, Magina S. Mechanisms regulating melanogenesis. An Bras Dermatol. 2013; 88:76-83.

  17. Bak H, Lee HJ, Chang SE, et al. Increased expression of nerve growth factor receptor and neural endopeptidase in the lesional skin of melasma. Dermatol Surg 2009; 35:1244.

  18. Sarkar R, Gokhale N, Godse K, et al. Medical Management of Melasma: A Review with Consensus Recommendations by Indian Pigmentary Expert Group. Indian J Dermatol. 2017;62(6):558-577. Fonte

  19. Vinay K, Bishnoi A, Parsad D, et al. Dermatoscopic evaluation and histopathological correlation of acquired dermal macular hyperpigmentation. Int J Dermatol 2017; 56:1395.

  20. McKesey J, Tovar-Garza A, Pandya AG. Melasma Treatment: An Evidence-Based Review. Am J Clin Dermatol. 2020;21(2):173-225. Fonte

  21. Austin E, Nguyen JK, Jagdeo J. Topical Treatments for Melasma: A Systematic Review of Randomized Controlled Trials. J Drugs Dermatol. 2019;18(11):S1545961619P1156X.

  22. Sarkar R, Aurangabadkar S, Salim T, et al. Lasers in Melasma: A Review with Consensus Recommendations by Indian Pigmentary Expert Group. Indian J Dermatol. 2017;62(6):585-590. Fonte

  23. Spierings NMK. Melasma: A critical analysis of clinical trials investigating treatment modalities published in the past 10 years. J Cosmet Dermatol. 2020;19(6):1284-1289. Fonte

  24. Dominguez AR, Balkrishnan R, Ellzey AR, Pandya AG. Melasma in Latina patients: cross-cultural adaptation and validation of a quality-of-life questionnaire in Spanish language. J Am Acad Dermatol. 2006;55(1):59-66. Fonte

  25. Cestari TF, Hexsel D, Viegas ML, et al. Validation of a melasma quality of life questionnaire for Brazilian Portuguese language: the MelasQoL-BP study and improvement of QoL of melasma patients after triple combination therapy. Br J Dermatol. 2006;156 Suppl 1:13-20. Fonte

  26. Pandya AG, Hynan LS, Bhore R, et al. Reliability assessment and validation of the Melasma Area and Severity Index (MASI) and a new modified MASI scoring method. J Am Acad Dermatol. 2011;64(1):78-83.e832. Fonte

Comente

3090D553-9492-4563-8681-AD288FA52ACE
Comentários são moderados. Veja os nossos Termos de Uso

processing....